What is it about?
The efficacy of Curcumin in controlling lung inflammation was reviewed in “Curcumin use in pulmonary diseases” in 2017, with over 85 citations. This concept letter article strongly hypothesize that the herbal antivirals Curcumin/Turmeric will reduce the viral load and modulate the cytokine-mediated inflammatory pathway involving IL-6, TNFα / NF-kβ, thereby suppressing the “cytokine storm”, significantly reducing morbidity and mortality, in COVID 19. Further, we recommend well design clinical trials to support this concept.
Featured Image
Photo by Sharon McCutcheon on Unsplash
Read the Original
This page is a summary of: Curcumin as a potential target for COVID19: Concept Letter, September 2021, Academia.edu,
DOI: 10.20935/al3484.
You can read the full text:
Contributors
The following have contributed to this page
